RAvulizumab to PRotect PaTients with Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI)

RAvulizumab to PRotect PaTients with Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study

Obert

Codi protocol: ALXN1210-CSA-AKI-318
Codi EudraCT: No aplica
Grup de recerca: Shock, Disfunció Orgànica i Ressuscitació
Servei: UCI ATR
Investigador/a principal: Ferrer Roca, Ricard
Malaltia: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase III
Estat: Reclutant voluntaris